Association between vascular endothelial growth factor +936 C/T gene polymorphism and age-related macular degeneration

Journal of International Medical Research

Volumn 41, Issue 2, 2013, Pages 317-324

  Jiang, Yanming ^a,b   Liang, Ge ^b   Wang, Liqiang ^a   Du, Jingjing Jianggaiping ^a   Huang, Yifei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Chinese PLA Second Artillery General Hospital   (China)

Author keywords

Age related macular degeneration; Gene polymorphism; Polymerase chain reaction; Restriction fragment length polymorphism; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

3' UNTRANSLATED REGION; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PREVALENCE; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETINA MACULA AGE RELATED DEGENERATION; SYNDROME DELINEATION; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE;

EID: 84878350428     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513475570     Document Type: Article

References (54)

1. Yang Z, Stratton C, Francis PJ, et al. Toll-like receptor 3 and geographic atrophy in agerelated macular degeneration. N Engl J Med 2008; 359: 1456-1463.
2. Jager RD, Mieler WF and Miller JW. Agerelated macular degeneration. N Engl J Med 2008; 358: 2606-2617.
3. de Jong PT. Age-related macular degeneration. N Engl J Med 2006; 355: 1474-1485.
4. Kaufman SR. Developments in age-related macular degeneration: diagnosis and treatment. Geriatrics 2009; 64: 16-19.
5. Evans J and Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996; 80: 9-14.
6. DeBlack SS. Cigarette smoking as a risk factor for cataract and age-related macular degeneration: a review of the literature. Optometry 2003; 74: 99-110.
7. Seddon JM, Reynolds R and Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis 2010; 16: 2412-2424.
8. Francis PJ, George S, Schultz DW, et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 2007; 63: 212-218.
9. Vojnikovic B, Micovic V, Coklo M, et al. Sun exposure and visual field damage among children on the Adriatic Island Rab-possible initial risk factor in development of agerelated macular degeneration. Coll Antropol 2009; 33: 747-749.
10. Metelitsina TI, Grunwald JE, DuPont JC, et al. Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br J Ophthalmol 2006; 90: 342-346.
11. Wang JJ, Rochtchina E, Smith W, et al. Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for agerelated macular degeneration in a cohort. Am J Epidemiol 2009; 169: 633-641.
12. Shahid H, Khan JC, Cipriani V, et al. Agerelated macular degeneration: the importance of family history as a risk factor. Br J Ophthalmol 2012; 96: 427-431.
13. Silvestri G, Johnston PB and Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye (Lond) 1994; 8: 564-568.
14. Soysal Y, Inan UU, Kusbeci T, et al. Agerelated macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population. DNA Cell Biol 2012; 31: 323-330.
15. Boekhoorn SS, Isaacs A, Uitterlinden AG, et al. Polymorphisms in the vascular endothelial growth factor gene and risk of agerelated macular degeneration: the Rotterdam Study. Ophthalmology 2008; 115: 1899-1903.
16. Witmer AN, Vrensen GF, Van Noorden CJ, et al. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22: 1-29.
17. Oishi A, Mandai M, Nishida A, et al. Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration. Eur J Ophthalmol 2011; 21: 777-782.
18. Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996; 93: 1493-1495.
19. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) 1999; 77: 527-543.
20. Ferrara N, Gerber HP and Le Couter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
21. Goncalves FM, Martins-Oliveira A, Speciali JG, et al. Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. DNA Cell Biol 2010; 29: 357-362.
22. Belo VA, Souza-Costa DC, Luizon MR, et al. Vascular endothelial growth factor haplotypes associated with childhood obesity. DNA Cell Biol 2011; 30: 709-714.
23. Lu Y, Shi Y, Xue C, et al. Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration. Mol Biol Rep 2012; 39: 6547-6553.
24. He Y, Ni J, Chen S, et al. The vascular endothelial growth factor-2549 insertion/ deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese. DNA Cell Biol 2010; 29: 393-396.
25. Mittal RD, Srivastava P, Singh V, et al. Association of common variants of vascular endothelial growth factor and interleukin-18 genes with allograft survival in renal transplant recipients of North India. DNA Cell Biol 2011; 30: 309-315.
26. Qu Y, Dai H, Zhou F, et al. Vascular endothelial growth factor gene polymorphisms and risk of neovascular age-related macular degeneration in a Chinese cohort. Ophthalmic Res 2011; 45: 142-148.
27. Ajaz S, Khaliq S, Abid A, et al. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma. Genet Test Mol Biomarkers 2011; 15: 653-657.
28. Zhang L, Zhang G, Wang P, et al. Association of vascular endothelial growth factor -2578C/A gene polymorphism in Chinese patients with colon cancer. Genet Test Mol Biomarkers 2011; 15: 117-121.
29. Almeida LN, Melilo-Carolino R, Veloso CE, et al. Homozygosity for the {thorn}674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort. Graefes Arch Clin Exp Ophthalmol 2012; 250: 185-189.
30. Nakata I, Yamashiro K, Nakanishi H, et al. VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration. Jpn J Ophthalmol 2011; 55: 435-443.
31. Galan A, Ferlin A, Caretti L, et al. Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 2010; 117: 1769-1774.
32. Szaflik JP, Blasiak J, Krzyanowska A, et al. Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration. Klin Oczna 2009; 111: 125-127.
33. Janik-Papis K, Zaras M, Krzyzanowska A, et al. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population. Exp Mol Pathol 2009; 87: 234-238.
34. Fang AM, Lee AY, Kulkarni M, et al. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular agerelated macular degeneration. Mol Vis 2009; 15: 2710-2719.
35. Lin JM, Wan L, Tsai YY, et al. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 2008; 145: 1045-1051.
36. Richardson AJ, Islam FM, Guymer RH, et al. A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis 2007; 13: 2148-2152.
37. Churchill AJ, Carter JG, Lovell HC, et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 2006; 15: 2955-2961.
38. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-374.
39. Bao G, Wang M, Guo S, et al. Vascular endothelial growth factor {thorn}936 C/T gene polymorphism and glioma risk in a Chinese Han population. Genet Test Mol Biomarkers 2011; 15: 103-106.
40. Yang S, Cao S, Li J, et al. Association between vascular endothelial growth factor {thorn}936 genotype and acute respiratory distress syndrome in a Chinese population. Genet Test Mol Biomarkers 2011; 15: 737-740.
41. Cao C, Fang JJ, Ying T, et al. Vascular endothelial growth factor {thorn}936 C/T and {thorn}405G/C polymorphisms and cancer risk: a meta-analysis. Arch Med Res 2010; 41: 548-557.
42. Cheng CY, Chang CS, Liu CJ, et al. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 79-84.
43. Bae SJ, Kim JW, Kang H, et al. Genderspecific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008; 28: 1271-1276.
44. Ikuhashi Y, Yoshida S, Kennedy S, et al. Vascular endothelial growth factor {thorn}936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population. Acta Obstet Gynecol Scand 2007; 86: 1352-1358.
45. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468-471.
46. Synowiec E, Szaflik J, Chmielewska M, et al. An association between polymorphism of the heme oxygenase-1 and -2 genes and agerelated macular degeneration. Mol Biol Rep 2012; 39: 2081-2087.
47. Canter JA, Olson LM, Spencer K, et al. Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS One 2008; 3: e2091.
48. Kondo N, Bessho H, Honda S, et al. Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and metaanalysis. Ophthalmology 2011; 118: 339-344.
49. Spencer KL, Olson LM, Anderson BM, et al. C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet 2008; 17: 1821-1824.
50. Tong Y, Liao J, Zhang Y, et al. LOC387715/ HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol Vis 2010; 16: 1958-1981.
51. Tang NP, Zhou B, Wang B, et al. HTRA1 promoter polymorphism and risk of agerelated macular degeneration: a meta-analysis. Ann Epidemiol 2009; 19: 740-745.
52. Chen W, Xu W, Tao Q, et al. Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration. Exp Eye Res 2009; 89: 292-300.
53. Sun C, Zhao M and Li X. CFB/C2 Gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis. Curr Eye Res 2012; 37: 259-271.
54. Hughes AE, Mullan GM and Bradley DT. Complement factor B polymorphism 32W protects against age-related macular degeneration. Mol Vis 2011; 17: 983-988.